Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
doi 10.21417/la2019fi
Full Text
Open PDFAbstract
Available in full text
Date
Unknown
Authors
Publisher
Adaptive Biotechnologies